Novavax to Present at the 14th Annual Needham Healthcare Conference

GAITHERSBURG, Md., April 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Stanley C. Erck, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference at 8:00 a.m. ET, April 15, 2015 in New York City at the Westin Grand Central Hotel.

A live webcast link for the presentation will be available via the company website at www.novavax.com under Investor Info/Events.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for ground-breaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the company's website, www.novavax.com.

CONTACT: Novavax, Inc.

         Barclay A. Phillips
         SVP, Chief Financial Officer and Treasurer

         Andrea N. Flynn, Ph.D.
         Senior Manager, Investor Relations

         [email protected]
         240-268-2000

         Russo Partners, LLC

         David Schull
         Todd Davenport, Ph.D.

         [email protected]
         [email protected]
         212-845-4271

You May Also Be Interested In

• Novavax's Nuvaxovid wins approval in U.S., EU, Japan for 2026-2027
• INTURAI VENTURES ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT
• Petrox Resources Corp. Announces Cooperation Agreement with PCC Digital and Bennu Holdings